It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said More: NICE rejects Sanofi's Sarclisa in preliminary guidelines Source: News
read moreThe research also suggests that coronavirus was more infectious than previously estimated More: EU lockdowns saved more than 3m lives, research indicates Source: News
read moreAbbvie’s Rinvoq matches BMS’ Orencia in head-to-head rheumatoid arthritis trial kblankenship Mon, 06/08/2020 – 10:18 More: Abbvie's Rinvoq matches BMS' Orencia in head-to-head rheumatoid arthritis trial Source: fierce
read moreFiercePharmaPolitics—FDA official leaves ‘Warp Speed’ to preserve independent regulatory power: report esagonowsky Mon, 06/08/2020 – 10:06 More: FiercePharmaPolitics—FDA official leaves 'Warp Speed' to preserve independent regulatory power: report Source: fierce
read moreOxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine kblankenship Mon, 06/08/2020 – 09:04 More: Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine Source: fierce
read moreAstraZeneca reportedly eyed a merger with Gilead. But does ‘Gileaz’ make sense? aliu Mon, 06/08/2020 – 06:40 More: AstraZeneca reportedly eyed a merger with Gilead. But does 'Gileaz' make sense? Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals